stockrow
Friday 6 November 2026
Export PCVX’s income statement to Excel — free account
Vaxcyte, Inc.
PCVX Healthcare Biotechnology
- EPS
- −61.5%
- Free cash flow
- −92.6%
Quarter to June 2026, against a year earlier
63.82
1.90
+3.07%
Follow PCVX
Alert me
Vaxcyte, Inc. (PCVX) Shares outstanding
Vaxcyte, Inc.'s shares outstanding at the end of fiscal 2025 was $136.1M, up 11.6% from $122.0M in fiscal 2024. At the end of the quarter to 30 June 2026 it was $144.5M. Over the past ten years it has ranged from $3.6M (fiscal 2018) to $136.1M (fiscal 2025) — the current reading is the highest in ten years. Vaxcyte, Inc. ranks 83rd of 600 Biotechnology companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $136.1M | 11.55% |
| FY2024 | $122.0M | 25.57% |
| FY2023 | $97.2M | 49.75% |
| FY2022 | $64.9M | 24.95% |
| FY2021 | $51.9M | 75.73% |
| FY2020 | $29.5M | 678.55% |
| FY2019 | $3.8M | 4.55% |
| FY2018 | $3.6M | — |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $144.5M | 3.57% |
| Mar 2026 | $139.5M | 2.51% |
| Dec 2025 | $136.1M | (0.08%) |
| Sep 2025 | $136.2M | 0.12% |
| 24 more quarters | Free account |
Against its own ten years
Low $3.6M
High $136.1M
Ten-year median
$58.4M
Current reading's percentile
100
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| IBRX ImmunityBio, Inc. compare | $1.1B |
| CAI Caris Life Sciences,�Inc. compare | $295.1M |
| BMRN BioMarin Pharmaceutical Inc. compare | $193.6M |
| TGTX TG Therapeutics, Inc. compare | $157.3M |
| TECH Bio-Techne Corp compare | $157.0M |
| PCVX Vaxcyte, Inc. | $144.5M |
| PTGX Protagonist Therapeutics, Inc. compare | $71.0M |
| TWST Twist Bioscience Corporation compare | $62.4M |
| MDGL Madrigal Pharmaceuticals, Inc. compare | $30.3M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item